EIP logo

Copyright © 2007-2024 European Immunogenicity Platform

Celerion

Celerion, a leading early clinical research organization, is equipped with the expertise and resources to surpass your bioanalytical needs, offering services from method development and validation to efficient sample analysis for studies spanning late discovery, preclinical, and late-stage clinical development. With more than 40 years of experience, our laboratories in Zürich, Switzerland, and Lincoln, Nebraska, USA, leverage cutting-edge technology and scientific expertise to accelerate drug development by swiftly providing high-quality data for thorough immunogenicity assessments, pharmacokinetics, and biomarker analysis.

For more information, please visit the Celerion website

Back to top